For insulin-resistant patients, this dual-action approach often leads to more sustainable metabolic improvement than appetite-focused GLP-1 medications alone, especially when guided by physician evaluation and lab-based care
BMJ 354 , i4857 (2016)
Medical Writing and Editorial Assistance The authors would like to thank Carsten Roepstorff, PhD, CR Pharma Consult, Copenhagen, Denmark for providing medical writing support, which was funded by Novo Nordisk
This higher dose is not the standard starting or maintenance dose for every patient and should only be used when specifically prescribed after appropriate assessment
Recent studies in human subjects show that sulforaphane elevates glutathione levels and those of other brain metabolites (56)
The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines .